SLNM Stock UPDATES Salon Media Group Inc. (SLNM) 0.2900 09/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Salon Media Group Inc. (SLNM) 0.2900 $SLNM

Salon Media Group Reports First Quarter Fiscal 2015 Results 60% Increase in Traffic Reported
Business Wire - Thu Aug 14, 3:04PM CDT
Salon Media Group, Inc. (OTCQB:SLNM) today announced its results for the three months ended June 30, 2014.

Salon Media Group Reports Full Year Fiscal 2014 Results
Business Wire - Thu Jun 26, 11:41PM CDT
Salon Media Group, Inc. (OTCQB:SLNM) today announced its results for the twelve months ended March 31, 2014. Net revenue from continuing operations for the period was $6.0 million, an increase of 65% from $3.6 million for the twelve months ended March 31, 2013. The improvement in revenues during fiscal year 2014 stemmed primarily from increased advertising sold by Salon's internal sales team, which rose 82% to $3.2 million for the twelve months ended March 31, 2014 compared to $1.7 million for the twelve months ended March 31, 2013.

Salon Media Group Reports 3rd Quarter Fiscal 2014 Results
Close-Up Media - Thu Feb 20, 12:17AM CST
Salon Media Group, Inc. announced its results for the three months and nine months ended December 31, 2013.

Salon Media Group Reports Third Quarter Fiscal 2014 Results
Business Wire - Fri Feb 14, 4:14PM CST
Salon Media Group, Inc. (OTCQB:SLNM) today announced its results for the three months and nine months ended December 31, 2013. Net revenue from continuing operations for the quarter ended December 31, 2013, was $1.9 million, an increase of 82% from the same period last year. For the nine months ended December 31, 2013, net revenue was $4.6 million, an increase of 70% versus the same period last year.

OTC Signal Daily Stock Watch - Salon Media Group (OTCQB: SLNM)
WorldStockWire - Fri Sep 06, 5:45PM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

Salon Media names David Daley as new Editor-In-Chief
M2 - Fri Aug 16, 7:19AM CDT
Salon Media Group Inc (OTC:SLNM) announced today that it has appointed David Daley to serve as its editor-in-chief, effective immediately. Daley had been serving as Salon's interim editor-in-chief since 5 June 2013.

Salon Media names David Daley as new editor-in-chief
M2 - Fri Aug 16, 3:55AM CDT
Salon Media Group Inc (OTCQB:SLNM), a company that operates the news site, Salon.com, revealed on Thursday that David Daley is taking over as its editor-in-chief with immediate effect.

Salon Media Group Appoints New Editor-In-Chief
Business Wire - Thu Aug 15, 5:42PM CDT
Salon Media Group, Inc. (OTCQB: SLNM) today announced the appointment of Mr. David Daley to serve as its Editor-In-Chief, effective immediately. Mr. Daley had been serving as Salon's Interim Editor-In-Chief since June 5, 2013.

Salon Media Group Reports First Quarter Fiscal 2014 Results
Business Wire - Wed Aug 14, 5:38PM CDT
Salon Media Group, Inc. (OTCQB: SLNM) today announced its results for the three months ended June 30, 2013. Net revenue from continuing operations for the quarter ended June 30, 2013, was $1.2 million, an increase of 43% from the same period last year.

Salon Media Group Reports Fourth Quarter and Year-End Results Major Traffic Increase Fuels Revenue Growth
Business Wire - Thu Jun 27, 5:00AM CDT
Salon Media Group, Inc. (OTCQB: SLNM) today announced its results for the three months and fiscal year ended March 31, 2013. Net revenue from continuing operations for the quarter ended March 31, 2013, was $0.9 million, an increase of 21% from the same period last year. Net revenue from continuing operations for the fiscal year ended March 31, 2013, was $3.6 million, an increase of 5% from the fiscal year ended March 31, 2012.

Salon Media Group Announces Recapitalization Results
Business Wire - Tue Mar 05, 7:05PM CST
Salon Media Group, Inc. (OTCQB: SLNM.PK) announced today that on March 1, 2013, it completed a recapitalization in which all of its convertible notes, related party advances and certain accrued consulting fees (aggregating $15,651,000, including interest on the convertible notes through February 28, 2013) and substantially all shares of its convertible preferred stock were exchanged for an aggregate of 72.87 million shares of common stock at a price of $0.35 per share.

Salon Media Group traffic increase fuels revenue growth
M2 - Tue Feb 19, 11:05AM CST
Salon Media Group, Inc. (OTC: SLNM) said its net revenues for the quarter ended December 31 increased 9 percent to $1.0 million compared to the same period last year.

Salon Media Group, Inc. Reports Third Quarter Results
Business Wire - Fri Feb 15, 4:59PM CST
Salon Media Group, Inc. (OTCQB: SLNM) today announced its results for the three months ended December 31, 2012. Net revenues for the quarter increased 9 percent to $1.0 million compared to the same period last year. Strong traffic growth at Salon.com resulted in a 23 percent increase in ad revenues for the three months ended December 31, 2012. The ad sales increase in the third quarter primarily stems from a 63 percent increase in third party sales to $0.6 million compared to $0.4 million for the three months ended December 31, 2011.

Salon.com partners with The Wine Spies to launch wine of the day store
M2 - Fri Dec 21, 12:32PM CST
The Wine Spies (thewinespies.com) said it has launched an online wine store in partnership with Salon Media Group.

Salon.com partners with leading online wine merchant The Wine Spies to launch wine of the day store
PR Newswire - Thu Dec 20, 6:00AM CST
The Wine Spies (thewinespies.com) today announce the launch of an online wine store in partnership with Salon Media Group (salon.com). Each day, the store (salon.com/thewinespies) will feature one carefully curated and attractively discounted wine offer that goes live at midnight Pacific. Wines are selected and reviewed by The Wine Spies, a leader in online wine retailing for nearly six years. The Wine Spies will also conduct the sale and handle shipping and customer service from their wine country headquarters.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading